- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04765072
Expanding Rural Health Cancer Control Capacity
July 12, 2023 updated by: Debra Friedman
Expanding Rural Health Cancer Control Capacity: Focus on Cancer Survivorship
Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties.
The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
Study Aims:
- Pilot test the implementation of guideline-based survivorship care planning in a rural setting using patient navigation plus telehealth among underserved rural cancer survivors. Investigators will collect feasibility data on patient recruitment rates and the ability to measure clinical effectiveness outcomes using the electronic health record and patient reports (survivor adherence to recommended disease surveillance, health assessment and cancer prevention/early detection practices).
- Identify the facilitators and barriers to future larger scale implementation of guideline-based survivorship care planning in rural settings to optimize the implementation strategies. Through a mixed methods approach, investigators will address implementation research questions focused on "real world" implementation of the guideline-based intervention in rural areas, including barriers/facilitators and translation to other rural settings. This will allow us to optimize the implementation strategies that will be further evaluated in the future large-scale implementation trial
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emma Schremp
- Phone Number: (615)936-2156
- Email: emma.schremp@vumc.org
Study Locations
-
-
Mississippi
-
Columbus, Mississippi, United States, 39705
- Baptist Cancer Center- Golden Triangle Columbus
-
Oxford, Mississippi, United States, 38655
- Baptist Cancer Center - North Mississippi
-
-
Tennessee
-
Bartlett, Tennessee, United States, 38133
- Baptist Cancer Center- Bartlett
-
Nashville, Tennessee, United States, 37232
- Vanderbilt-Ingram Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Cancer patient at least 18 years of age at time of cancer therapy
- English-speaking with the ability to provide informed consent
- Received treatment for Stage 0 - III cancer with curative intent
- Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Survivorship care
Participants in rural areas will receive a telehealth (providing health-related services through electronic communication technologies) survivorship care plan in combination with assistance from a patient navigator.
|
Patient navigator assistance for navigating the healthcare system and locating and utilizing beneficial resources
Individualized survivorship care plan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rate of improvement in adherence to survivorship plan (Survivorship Care Planning Experience Satisfaction Survey (1-5 Excellent - Poor)
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Measure effectiveness of Telehealth on survivorship care
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Estimate the facilitators to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Time Frame: Approximately 1 year
|
Approximately 1 year
|
Estimate the barriers to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Time Frame: Approximately 1 year
|
Approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Debra Friedman, MD, Vanderbilt-Ingram Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 26, 2021
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2029
Study Registration Dates
First Submitted
February 12, 2021
First Submitted That Met QC Criteria
February 17, 2021
First Posted (Actual)
February 21, 2021
Study Record Updates
Last Update Posted (Actual)
July 14, 2023
Last Update Submitted That Met QC Criteria
July 12, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- VICC PED 2019
- 3P30CA068485-24S2 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Survivorship Patient Navigation Intervention
-
Boston Medical CenterBoston University; Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center and other collaboratorsCompleted
-
University of Colorado, DenverDenver Health and Hospital Authority; Rocky Mountain Human Services; El Grupo...Completed
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedSexual Behavior | Substance AbuseUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Kaiser PermanenteNational Cancer Institute (NCI); Sea Mar Community Health CentersCompletedColorectal CancerUnited States
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedPrevention Harmful Effects | Compliance Behavior | Non-Small Cell Lung CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...CompletedBreast CancerUnited States
-
Northwestern UniversityNortheastern Illinois UniversityRecruiting
-
University College CorkSidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Cork University... and other collaboratorsActive, not recruitingCervical Cancer | Breast Cancer | Endometrial Cancer | SurvivorshipIreland
-
Renato Cagnacci NetoM.D. Anderson Cancer Center; Eduardo Mondlane University; Hospital Central de... and other collaboratorsNot yet recruitingA Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients (NAVIMOZ)Breast Neoplasm Malignant Primary